tecentriq solution
hoffmann-la roche limited - atÉzolizumab - solution - 840mg - atÉzolizumab 840mg - antineoplastic agents
lucentis solution
novartis pharmaceuticals canada inc - ranibizumab - solution - 10mg - ranibizumab 10mg - eent drugs, miscellaneous
cimzia solution
ucb canada inc - certolizumab pégol - solution - 200mg - certolizumab pégol 200mg - miscellaneous gi drugs
lucentis solution
novartis pharmaceuticals canada inc - ranibizumab - solution - 10mg - ranibizumab 10mg - eent drugs, miscellaneous
cimzia solution
ucb canada inc - certolizumab pégol - solution - 200mg - certolizumab pégol 200mg - miscellaneous gi drugs
zirabev solution
pfizer canada ulc - bévacizumab - solution - 100mg - bévacizumab 100mg - antineoplastic agents
zirabev solution
pfizer canada ulc - bévacizumab - solution - 400mg - bévacizumab 400mg - antineoplastic agents
kanjinti trousse
amgen canada inc - trastuzumab - trousse - 420mg - trastuzumab 420mg - antineoplastic agents
phesgo solution
hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 40mg; 80mg - trastuzumab 40mg; pertuzumab 80mg - antineoplastic agents
phesgo solution
hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 60mg; 60mg - trastuzumab 60mg; pertuzumab 60mg - antineoplastic agents